SAMSARA BIOCAPITAL, LLC

13F Portfolio Filings

Most recent 13F
Q2 2026
Location
Palo Alto, CA
CIK
0001744967
All SEC filings
View on sec.gov
Holdings Value, Excluding Options
Quarter Holdings Value, Excl. Options ($000) Top Holdings Form Type Date Filed Filing ID
Q2 2026 24 1,217,462 SRRK, ALMS, MLYS, SEPN 13F-HR 8/14/2026 000174496726000010
Q1 2026 22 1,029,103 SRRK, MLYS, ALMS, SEPN 13F-HR 5/15/2026 000174496726000005
Q4 2025 21 969,257 SRRK, MLYS, KLRS, SEPN 13F-HR 2/17/2026 000174496726000002
Q3 2025 27 765,929 MLYS, SRRK, KLRS, SEPN 13F-HR 11/14/2025 000174496725000004
Q2 2025 29 488,945 SRRK, MLYS, SEPN, KLRS 13F-HR 8/14/2025 000141588925021908
Q1 2025 37 560,807 SRRK, KLRS, MLYS, NGNE 13F-HR 5/15/2025 000141588925013106
Q4 2024 43 728,583 SRRK, CRGX, SEPN, MLYS 13F-HR 2/14/2025 000110465925014316
Q3 2024 42 520,277 CRGX, MLYS, SRRK, NGNE 13F-HR 11/14/2024 000110465924118933
Q2 2024 40 477,799 CRGX, MLYS, SRRK, NGNE 13F-HR 8/14/2024 000110465924089652
Q1 2024 39 646,373 SRRK, CRGX, MLYS, NGNE 13F-HR 5/15/2024 000110465924061946
Q4 2023 41 642,801 SRRK, RYZB, CRGX, MLYS 13F-HR 2/14/2024 000110465924023801
Q3 2023 41 326,685 MLYS, RYZB, SRRK, SLRN 13F-HR 11/14/2023 000110465923118112
Q2 2023 47 569,734 KDNY, MLYS, SLRN, SRRK 13F-HR 8/14/2023 000110465923091467
Q1 2023 56 483,843 KDNY, MLYS, SRRK, ACLX RESTATEMENT 8/14/2023 000110465923091466
Q4 2022 1 3,164 SYRS NEW HOLDINGS 2/15/2023 000110465923022435
Q4 2022 54 461,242 KDNY, SRRK, ACLX, GRPH 13F-HR 2/14/2023 000110465923021783
Q3 2022 56 428,436 KDNY, NKTX, SRRK, GRPH 13F-HR 11/14/2022 000110465922118511
Q2 2022 57 373,940 KDNY, NKTX, SRRK, GRPH 13F-HR 8/15/2022 000110465922091195
Q1 2022 57 395,488 KDNY, GRPH, NKTX, TIL 13F-HR 5/16/2022 000110465922061327
Q4 2021 51 501,995 GRPH, KDNY, TIL, NKTX 13F-HR 2/14/2022 000110465922022413
Q3 2021 48 602,408 GRPH, NKTX, KDNY, TIL 13F-HR 11/15/2021 000110465921139230
Q2 2021 50 760,817 GRPH, NKTX, KDNY, NVAX calls 13F-HR 8/16/2021 000110465921106652
Q1 2021 44 496,668 NKTX, KDNY, FMTX, TIL 13F-HR 5/17/2021 000110465921068346
Q4 2020 43 994,430 JYAC, NKTX, KDNY, FMTX 13F-HR 2/17/2021 000110465921024479
Q3 2020 36 358,514 FMTX, NKTX, ISEE, SWTX 13F-HR 11/16/2020 000110465920125923
Q2 2020 32 310,856 FMTX, SWTX, ODTC, PRNB 13F-HR 8/14/2020 000110465920095488
Q1 2020 28 173,758 ICPT, PRNB, SWTX, ODTC 13F-HR 5/15/2020 000110465920062544
Q4 2019 19 208,709 ICPT, SWTX, ALLK, ODTC 13F-HR 2/18/2020 000110465920022343
Q3 2019 18 146,925 ICPT, ALLK, SYRS, SWTX 13F-HR 11/14/2019 000110465919064283
Q2 2019 21 151,361 ICPT, ODTC, ALLK, SYRS 13F-HR 8/14/2019 000110465919045918
Q1 2019 18 127,246 ICPT, ALLK, ODTC, PRNB 13F-HR 5/15/2019 000110465919029784
Q4 2018 17 104,187 ALLK, ICPT, PRNB, STRO 13F-HR 2/14/2019 000110465919008738
Additional filings from Samsara Biocapital, LLC that have since been restated